PGEN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 41.70%

Insider Buying (Last 12 Months): $1,039,887.87

Insider Selling (Last 12 Months): $513,769.48

Precigen Insider Trading History Chart

Precigen Share Price & Price History

^$1.42

▲ +0.02 (1.43%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Precigen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/28/2023	Randal J. Kirk	Director	Buy	96,686	$1.41	$136,327.26	1,096,686
9/22/2023	Dean J Mitchell	Director	Buy	25,000	$1.41	$35,250.00	356,836
8/25/2023	Helen Sabzevari	CEO	Sell	76,969	$1.53	$117,762.57	1,560,004
8/24/2023	Donald P. Lehr	Insider	Sell	10,947	$1.64	$17,953.08	428,916
8/24/2023	Harry Thomasian, Jr.	CFO	Sell	9,045	$1.64	$14,833.80	161,051
8/24/2023	Jeffrey Thomas Perez	SVP	Sell	8,891	$1.64	$14,581.24	458,903
8/24/2023	Rutul R Shah	COO	Sell	5,388	$1.64	$8,836.32	133,474
8/18/2023	Helen Sabzevari	CEO	Sell	55,855	$1.66	$92,719.30	1,495,386
8/17/2023	Donald P. Lehr	Insider	Sell	10,762	$1.55	$16,681.10	418,153
8/17/2023	Harry Thomasian, Jr.	CFO	Sell	8,893	$1.55	$13,784.15	152,162
8/17/2023	Jeffrey Thomas Perez	SVP	Sell	8,741	$1.55	$13,548.55	448,916
8/17/2023	Rutul R Shah	COO	Sell	5,298	$1.55	$8,211.90	123,382
8/16/2023	Randal J. Kirk	Director	Buy	119,411	$1.51	$180,310.61	31,837,786
8/14/2023	Steven Frank	Director	Buy	400,000	$1.72	$688,000.00	882,358
8/11/2023	Helen Sabzevari	CEO	Sell	41,436	$1.44	$59,667.84	1,409,654
8/10/2023	Donald P. Lehr	Insider	Sell	11,026	$1.21	$13,341.46	407,205
8/10/2023	Harry Thomasian, Jr.	CFO	Sell	6,852	$1.21	$8,290.92	143,121
8/10/2023	Jeffrey Thomas Perez	SVP	Sell	8,956	$1.21	$10,836.76	438,779
8/10/2023	Rutul R Shah	COO	Sell	5,429	$1.21	$6,569.09	113,200
8/4/2023	Helen Sabzevari	CEO	Sell	52,870	$1.10	$58,157.00	1,309,503
8/3/2023	Donald P. Lehr	Insider	Sell	10,821	$1.20	$12,985.20	396,521
8/3/2023	Harry Thomasian, Jr.	CFO	Sell	6,724	$1.20	$8,068.80	132,039
8/3/2023	Jeffrey Thomas Perez	SVP	Sell	8,789	$1.20	$10,546.80	428,857
8/3/2023	Rutul R Shah	COO	Sell	5,328	$1.20	$6,393.60	103,149
1/27/2023	Helen Sabzevari	CEO	Buy	22,857	$1.75	$39,999.75	937,613
1/27/2023	Jeffrey Thomas Perez	SVP	Buy	28,571	$1.75	$49,999.25	381,012
1/27/2023	Randal J. Kirk	Director	Buy	11,428,571	$1.75	$19,999,999.25	31,129,164
1/27/2023	Rutul R Shah	COO	Buy	9,142	$1.75	$15,998.50	62,037
8/23/2022	Harry Thomasian, Jr.	CFO	Buy	24,500	$2.09	$51,205.00	56,390
8/11/2022	Jeffrey B Kindler	Director	Sell	50,000	$2.30	$115,000.00	214,411
5/17/2022	Donald P. Lehr	Insider	Sell	18,196	$1.28	$23,290.88	323,274
5/17/2022	Harry Thomasian, Jr.	CFO	Sell	2,719	$1.28	$3,480.32	31,890
5/17/2022	Jeffrey Thomas Perez	SVP	Sell	14,778	$1.28	$18,915.84	333,502
5/13/2022	Helen Sabzevari	CEO	Sell	177,968	$1.19	$211,781.92	897,091
1/5/2022	Donald P. Lehr	Insider	Sell	10,356	$3.59	$37,178.04
1/5/2022	Helen Sabzevari	CEO	Sell	6,960	$3.59	$24,986.40
1/5/2022	Jeffrey Thomas Perez	SVP	Sell	9,738	$3.59	$34,959.42
1/3/2022	Donald P. Lehr	Insider	Sell	5,315	$3.67	$19,506.05
1/3/2022	Helen Sabzevari	CEO	Sell	3,848	$3.67	$14,122.16
1/3/2022	Jeffrey Thomas Perez	SVP	Sell	5,022	$3.67	$18,430.74
11/26/2021	Harry Thomasian, Jr.	CFO	Buy	26,500	$3.80	$100,700.00
11/22/2021	Randal J. Kirk	Director	Buy	206,004	$3.59	$739,554.36
11/19/2021	Randal J. Kirk	Director	Buy	307,661	$3.75	$1,153,728.75
10/13/2021	Trading S.A. Ares	Major Shareholder	Sell	79,896	$4.60	$367,521.60
10/11/2021	Trading S.A. Ares	Major Shareholder	Sell	68,900	$4.67	$321,763.00
10/8/2021	Trading S.A. Ares	Major Shareholder	Sell	47,304	$4.69	$221,855.76
10/6/2021	Trading S.A. Ares	Major Shareholder	Sell	47,800	$4.88	$233,264.00
10/4/2021	Trading S.A. Ares	Major Shareholder	Sell	9,700	$5.02	$48,694.00
9/30/2021	Trading S.A. Ares	Major Shareholder	Sell	100	$5.10	$510.00
9/10/2021	Trading S.A. Ares	Major Shareholder	Sell	4,584	$6.29	$28,833.36
9/8/2021	Trading S.A. Ares	Major Shareholder	Sell	2,400	$6.23	$14,952.00
9/3/2021	Trading S.A. Ares	Major Shareholder	Sell	29,065	$6.42	$186,597.30	21,193,911
9/1/2021	Trading S.A. Ares	Major Shareholder	Sell	254,932	$6.21	$1,583,127.72	21,362,391
8/30/2021	Trading S.A. Ares	Major Shareholder	Sell	30,000	$5.97	$179,100.00	21,637,323
8/26/2021	Trading S.A. Ares	Major Shareholder	Sell	111,229	$5.95	$661,812.55
8/24/2021	Trading S.A. Ares	Major Shareholder	Sell	33,407	$5.86	$195,765.02
8/16/2021	Trading S.A. Ares	Major Shareholder	Sell	6,313	$6.13	$38,698.69
8/13/2021	Trading S.A. Ares	Major Shareholder	Sell	52,031	$6.20	$322,592.20
8/11/2021	Trading S.A. Ares	Major Shareholder	Sell	257,800	$6.11	$1,575,158.00	22,057,787
8/9/2021	Trading S.A. Ares	Major Shareholder	Sell	56,528	$5.59	$315,991.52	22,568,520
8/5/2021	Trading S.A. Ares	Major Shareholder	Sell	159,703	$5.50	$878,366.50	22,697,748
8/3/2021	Trading S.A. Ares	Major Shareholder	Sell	2,100	$5.49	$11,529.00
7/29/2021	Trading S.A. Ares	Major Shareholder	Sell	18,247	$5.69	$103,825.43	22,885,249
7/19/2021	Helen Sabzevari	CEO	Sell	12,531	$5.43	$68,043.33
6/28/2021	Trading S.A. Ares	Major Shareholder	Sell	24,839	$6.88	$170,892.32	22,903,496
6/24/2021	Trading S.A. Ares	Major Shareholder	Sell	178,623	$6.77	$1,209,277.71	23,108,805
6/14/2021	Trading S.A. Ares	Major Shareholder	Sell	55,541	$7.13	$396,007.33	23,342,969
6/11/2021	Trading S.A. Ares	Major Shareholder	Sell	509,467	$7.57	$3,856,665.19	23,342,969
6/9/2021	Trading S.A. Ares	Major Shareholder	Sell	155,227	$7.22	$1,120,738.94	23,944,427
6/7/2021	Trading S.A. Ares	Major Shareholder	Sell	203,233	$6.97	$1,416,534.01	24,325,910
6/3/2021	Trading S.A. Ares	Major Shareholder	Sell	83,992	$6.59	$553,507.28	24,605,828
5/28/2021	Trading S.A. Ares	Major Shareholder	Sell	72,811	$6.79	$494,386.69	24,917,820
5/26/2021	Trading S.A. Ares	Major Shareholder	Sell	169,000	$6.60	$1,115,400.00	25,156,778
5/24/2021	Trading S.A. Ares	Director	Sell	62,469	$6.57	$410,421.33	25,412,066
5/21/2021	Trading S.A. Ares	Major Shareholder	Sell	131,409	$6.86	$901,465.74	25,605,944
5/19/2021	Donald P. Lehr	Insider	Sell	8,907	$6.63	$59,053.41	300,754
5/19/2021	Trading S.A. Ares	Major Shareholder	Sell	121,500	$6.50	$789,750.00	25,877,092
5/17/2021	Trading S.A. Ares	Major Shareholder	Sell	79,355	$6.75	$535,646.25	26,090,490
5/14/2021	Trading S.A. Ares	Major Shareholder	Sell	185,360	$6.71	$1,243,765.60	26,090,490
5/13/2021	Helen Sabzevari	CEO	Sell	47,433	$6.40	$303,571.20	752,490
5/12/2021	Trading S.A. Ares	Major Shareholder	Sell	150,000	$7.00	$1,050,000.00	26,398,239
5/10/2021	Trading S.A. Ares	Major Shareholder	Sell	114,603	$6.34	$726,583.02	26,699,403
5/7/2021	Trading S.A. Ares	Major Shareholder	Sell	150,000	$6.55	$982,500.00	26,964,006
5/5/2021	Trading S.A. Ares	Major Shareholder	Sell	57,261	$6.86	$392,810.46	27,121,267
5/3/2021	Trading S.A. Ares	Major Shareholder	Sell	182,302	$7.72	$1,407,371.44	27,290,389
4/30/2021	Trading S.A. Ares	Major Shareholder	Sell	108,130	$7.90	$854,227.00	27,290,389

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for Precigen (NASDAQ:PGEN)

33.51% of Precigen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Precigen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Simplicity Wealth LLC	35,204	$51K	0.0%	N/A	0.014%
4/11/2024	Sanders Morris Harris LLC	705,000	$1.02M	0.2%	N/A	0.283%
4/10/2024	LexAurum Advisors LLC	89,166	$0.13M	0.0%	-8.8%	0.036%
3/5/2024	Fisher Asset Management LLC	21,800	$29K	0.0%	N/A	0.009%
2/20/2024	MSD Partners L.P.	355,000	$0.48M	0.0%	-63.0%	0.143%
2/15/2024	Opaleye Management Inc.	1,012,500	$1.36M	0.4%	+9.0%	0.407%
2/15/2024	Patient Capital Management LLC	15,983,700	$21.42M	1.1%	+16.2%	6.421%
2/12/2024	Chiron Capital Management LLC	24,050	$32K	0.0%	-56.9%	0.010%
2/8/2024	Panagora Asset Management Inc.	303,385	$0.41M	0.0%	N/A	0.122%
2/6/2024	Fisher Asset Management LLC	21,800	$29K	0.0%	N/A	0.009%
1/30/2024	Emfo LLC	519,475	$0.70M	0.6%	+22.2%	0.209%
1/29/2024	Simplicity Solutions LLC	34,245	$46K	0.0%	-23.9%	0.014%
1/26/2024	Iridian Asset Management LLC CT	2,004,934	$2.69M	0.5%	-3.5%	0.805%
1/25/2024	Bleakley Financial Group LLC	34,245	$46K	0.0%	-23.9%	0.014%
1/24/2024	China Universal Asset Management Co. Ltd.	28,788	$39K	0.0%	+338.8%	0.012%
1/12/2024	SG Americas Securities LLC	76,352	$0.10M	0.0%	+12.5%	0.031%
1/8/2024	Diversified Trust Co	29,126	$39K	0.0%	N/A	0.012%
1/5/2024	Exchange Traded Concepts LLC	94,091	$0.13M	0.0%	+34.0%	0.038%
11/14/2023	Caxton Associates LP	34,863	$50K	0.0%	-55.3%	0.014%
11/14/2023	Synovus Financial Corp	49,065	$70K	0.0%	-52.9%	0.020%
11/8/2023	State Board of Administration of Florida Retirement System	38,560	$55K	0.0%	N/A	0.015%
11/7/2023	Virtus ETF Advisers LLC	79,754	$0.11M	0.1%	-9.1%	0.031%
11/6/2023	Fore Capital LLC	426,791	$0.61M	0.3%	-12.9%	0.167%
11/4/2023	Magnolia Capital Advisors LLC	39,997	$57K	0.1%	N/A	0.016%
11/1/2023	Emfo LLC	425,000	$0.60M	0.6%	+136.1%	0.166%
10/30/2023	Iridian Asset Management LLC CT	2,078,220	$2.95M	0.6%	-37.7%	0.813%
10/24/2023	Bank of New York Mellon Corp	455,238	$0.65M	0.0%	+5.2%	0.178%
10/18/2023	Exchange Traded Concepts LLC	70,232	$100K	0.0%	-34.8%	0.027%
10/16/2023	LexAurum Advisors LLC	92,666	$0.13M	0.0%	-9.1%	0.036%
10/13/2023	SG Americas Securities LLC	67,874	$96K	0.0%	N/A	0.027%
10/13/2023	Sanders Morris Harris LLC	410,000	$0.58M	0.1%	+26.2%	0.160%
10/5/2023	Sanders Morris Harris LLC	410,000	$0.58M	0.2%	+26.2%	0.160%
9/21/2023	Barclays PLC	48,856	$55K	0.0%	-41.5%	0.019%
8/14/2023	Graham Capital Management L.P.	36,127	$42K	0.0%	N/A	0.014%
8/9/2023	Iridian Asset Management LLC CT	3,333,468	$3.83M	0.4%	-6.6%	1.305%
8/7/2023	Principal Financial Group Inc.	65,326	$75K	0.0%	+34.7%	0.026%
8/3/2023	Emfo LLC	180,000	$0.21M	0.2%	N/A	0.070%
8/3/2023	Los Angeles Capital Management LLC	213,294	$0.25M	0.0%	-50.7%	0.083%
7/24/2023	Allspring Global Investments Holdings LLC	52,272	$60K	0.0%	+1,092.3%	0.020%
7/20/2023	Exchange Traded Concepts LLC	107,685	$0.12M	0.0%	N/A	0.042%
7/18/2023	Allspring Global Investments Holdings LLC	52,272	$60K	0.0%	+1,092.3%	0.020%
7/13/2023	Cambridge Investment Research Advisors Inc.	75,534	$87K	0.0%	+12.9%	0.030%
7/11/2023	Sanders Morris Harris LLC	325,000	$0.37M	0.1%	+27.5%	0.127%
5/11/2023	Synovus Financial Corp	104,065	$0.11M	0.0%	+112.1%	0.041%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	154,489	$0.16M	0.0%	-72.4%	0.060%
5/9/2023	GMT Capital Corp	668,830	$0.71M	0.0%	N/A	0.262%
5/9/2023	Fore Capital LLC	490,000	$0.52M	0.3%	+366.7%	0.192%
5/8/2023	ClariVest Asset Management LLC	266,856	$0.28M	0.0%	N/A	0.104%
5/4/2023	Summit Trail Advisors LLC	104,529	$0.11M	0.0%	+144.3%	0.041%
5/4/2023	Los Angeles Capital Management LLC	432,736	$0.46M	0.0%	-3.0%	0.169%
4/28/2023	SG Americas Securities LLC	52,354	$55K	0.0%	+48.2%	0.020%
4/28/2023	Janney Montgomery Scott LLC	45,813	$49K	0.0%	-17.7%	0.018%
4/28/2023	Iridian Asset Management LLC CT	3,569,266	$3.78M	0.3%	+23.9%	1.397%
4/27/2023	Simplicity Solutions LLC	39,070	$41K	0.0%	N/A	0.015%
4/27/2023	Arizona State Retirement System	43,638	$46K	0.0%	+48.6%	0.017%
4/21/2023	Chiron Capital Management LLC	46,650	$49K	0.0%	-32.9%	0.018%
4/7/2023	Sanders Morris Harris LLC	255,000	$0.27M	0.1%	+183.3%	0.101%
3/23/2023	MetLife Investment Management LLC	17,466	$27K	0.0%	-67.8%	0.007%
2/14/2023	Patient Capital Management LLC	798,200	$1.21M	0.6%	+167.7%	0.318%
2/13/2023	American Financial Group Inc.	66,114	$100K	0.0%	N/A	0.026%
2/13/2023	The Manufacturers Life Insurance Company	43,234	$66K	0.0%	+96.8%	0.017%
2/13/2023	GSA Capital Partners LLP	247,945	$0.38M	0.0%	-31.4%	0.099%
2/10/2023	O Shaughnessy Asset Management LLC	17,719	$27K	0.0%	N/A	0.007%
2/7/2023	Cassaday & Co Wealth Management LLC	25,000	$38K	0.0%	N/A	0.010%
2/7/2023	Bleakley Financial Group LLC	37,607	$57K	0.0%	N/A	0.015%
2/6/2023	Los Angeles Capital Management LLC	445,898	$0.68M	0.0%	-10.3%	0.178%
2/6/2023	Ieq Capital LLC	16,528	$25K	0.0%	N/A	0.007%
2/2/2023	SG Americas Securities LLC	35,326	$54K	0.0%	-41.1%	0.014%
1/31/2023	Iridian Asset Management LLC CT	2,879,612	$4.38M	0.4%	-10.3%	1.383%
1/26/2023	Inspire Advisors LLC	47,079	$72K	0.0%	+21.8%	0.023%
1/26/2023	Strs Ohio	50,200	$76K	0.0%	N/A	0.024%
1/23/2023	Chiron Capital Management LLC	69,498	$0.11M	0.1%	+50.2%	0.033%
1/23/2023	LexAurum Advisors LLC	109,971	$0.17M	0.1%	-26.0%	0.053%
1/19/2023	Pendal Group Ltd	99,195	$0.15M	0.0%	N/A	0.048%
11/15/2022	Northeast Financial Consultants Inc	164,209	$0.35M	0.0%	-23.3%	0.079%
11/15/2022	Patient Capital Management LLC	298,200	$0.63M	0.3%	-83.4%	0.143%
11/14/2022	Tudor Investment Corp Et Al	73,836	$0.16M	0.0%	+150.6%	0.035%
11/14/2022	AXA S.A.	412,200	$0.87M	0.0%	+1,582.4%	0.198%
11/14/2022	MetLife Investment Management LLC	54,255	$0.12M	0.0%	N/A	0.026%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	555,574	$1.18M	0.0%	+337.3%	0.267%
11/9/2022	Sanford Advisory Services LLC	15,102	$32K	0.0%	N/A	0.007%
11/7/2022	Iridian Asset Management LLC CT	3,209,904	$6.81M	0.7%	-14.7%	1.542%
11/3/2022	Teacher Retirement System of Texas	34,004	$72K	0.0%	+128.8%	0.016%
11/3/2022	The Manufacturers Life Insurance Company	21,965	$47K	0.0%	N/A	0.011%
11/3/2022	Barclays PLC	26,184	$55K	0.0%	+416.4%	0.013%
11/2/2022	Los Angeles Capital Management LLC	497,190	$1.05M	0.0%	-18.9%	0.239%
10/17/2022	Cambridge Investment Research Advisors Inc.	51,204	$0.11M	0.0%	-13.0%	0.025%
8/12/2022	Virtus ETF Advisers LLC	85,000	$0.11M	0.0%	+93.5%	0.041%
8/11/2022	Cetera Investment Advisers	159,975	$0.21M	0.0%	+6.9%	0.077%
8/10/2022	Synovus Financial Corp	44,065	$59K	0.0%	-14.8%	0.021%
8/10/2022	Inspire Investing LLC	26,170	$35K	0.0%	+57.5%	0.013%
8/9/2022	Swiss National Bank	243,700	$0.33M	0.0%	+10.8%	0.117%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	127,039	$0.17M	0.0%	+315.4%	0.061%
8/5/2022	Los Angeles Capital Management LLC	612,701	$0.82M	0.0%	-2.6%	0.295%
8/1/2022	ProShare Advisors LLC	27,513	$37K	0.0%	-29.8%	0.013%
7/29/2022	SG Americas Securities LLC	65,489	$88K	0.0%	-27.1%	0.032%
7/29/2022	Iridian Asset Management LLC CT	3,761,120	$5.04M	0.4%	+2.1%	1.811%
7/25/2022	Allspring Global Investments Holdings LLC	19,006	$25K	0.0%	-65.5%	0.009%
7/25/2022	Chiron Capital Management LLC	49,776	$67K	0.0%	-30.4%	0.024%
7/18/2022	Brinker Capital Investments LLC	28,930	$39K	0.0%	N/A	0.014%

Data available starting January 2016

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients; AdenoVerse immunotherapy, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and ActoBiotics for specific disease modification. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV-associated cancer; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis, as well as AG019, which is based on the ActoBiotics platform and in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Today's Range

Now: $1.42

$1.39

$1.43

50 Day Range

MA: $1.46

$1.31

$1.75

52 Week Range

Now: $1.42

$0.84

$1.88

Volume

558,930 shs

Average Volume

726,506 shs

Market Capitalization

$353.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Who are the company insiders with the largest holdings of Precigen?: Precigen's top insider investors include:
Randal J Kirk (Director)
Helen Sabzevari (CEO)
Steven Frank (Director)
Jeffrey Thomas Perez (SVP)
Donald P Lehr (Insider)
Dean J Mitchell (Director)
Jeffrey B Kindler (Director)
Harry Jr Thomasian (CFO)
Rutul R Shah (COO)
Learn More about top insider investors at Precigen.
Who are the major institutional investors of Precigen?: Precigen's top institutional investors include:
Sanders Morris Harris LLC — 0.28%
LexAurum Advisors LLC — 0.04%
Simplicity Wealth LLC — 0.01%
Learn More about top institutional investors of Precigen stock.
Which major investors are selling Precigen stock?: During the last quarter, PGEN stock was sold by these institutional investors:
LexAurum Advisors LLC
During the last year, company insiders that have sold Precigen company stock include:
Randal J Kirk (Director)
Helen Sabzevari (CEO)
Steven Frank (Director)
Jeffrey Thomas Perez (SVP)
Donald P Lehr (Insider)
Learn More investors selling Precigen stock.
Which major investors are buying Precigen stock?: Within the previous quarter, PGEN stock was purchased by institutional investors including:
Sanders Morris Harris LLC
Simplicity Wealth LLC
In the previous year, these company insiders have bought Precigen stock:
Randal J Kirk (Director)
Helen Sabzevari (CEO)
Steven Frank (Director)
Jeffrey Thomas Perez (SVP)
Donald P Lehr (Insider)
Dean J Mitchell (Director)
Jeffrey B Kindler (Director)
Learn More investors buying Precigen stock.